ENDRA Life Sciences Inc. (NDRA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2023-03-16. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

787.0K
Year ended 2025-12-31
2023-12-31: 3.6K2024-12-31: 202.1K2025-12-31: 787.0K787.0K
2023-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31787.0K+289.4%2026-03-31, From 2025-01-01
2024-12-31202.1Kn/m2026-03-31, From 2024-01-01
2023-12-313.6Kn/a2025-04-07, From 2023-01-01